Stephanie Kennan on Centers for Medicare & Medicaid Services (CMS)

Washington Healthcare Update - April 2020 #2

This week in Washington: The Senate reconvenes April 13 to continue negotiations on the next COVID-19 stimulus package; the House is expected to reconvene April 20....more

4/14/2020 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Pharmaceutical Industry , Telehealth , Trump Administration

HHS Begins Funding $30 Billion to Medicare Providers – Attestations to Be Required

Update: This article was originally published on April 9, 2020. It has been updated to reflect new guidance released on April 10, 2020, by the Department of Health and Human Services (HHS) regarding the delivery of the...more

4/13/2020 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Health Care Providers , Medicare

First $30 Billion Tranche From Public Health and Social Services Emergency Fund Announced: Guidance for Healthcare Providers

During an April 7, 2020, White House briefing on the 2019 novel coronavirus (COVID-19), the Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma announced more details on distribution of the $100 billion...more

4/10/2020 / CARES Act , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Health Care Providers

Washington Healthcare Update - April 2020 #1

This week in Washington: The Senate and the House are not scheduled to return to the Hill until the week of April 20 and are currently in a district work period....more

4/7/2020 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , MACPAC

CMS Provides Guidance to States on Enhanced Medicaid Funding During COVID-19

On March 24, 2020, the Centers for Medicare & Medicaid Services provided guidance to states concerning enhanced federal Medicaid funding during the 2019 novel coronavirus national emergency....more

3/25/2020 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Health Care Providers , Infectious Diseases

Washington Healthcare Update - March 2020 #4

This week in Washington: Congress debates additional legislation to address the coronavirus (COVID-19) pandemic. ...more

3/24/2020 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Medicare Part D , Prescription Drugs , Trump Administration

HHS Acts to Support Telehealth Services in Response to COVID-19: Six Key Takeaways

The unprecedented public health emergency created by the coronavirus disease (COVID-19) has sparked action by the U.S. government to ensure greater access to healthcare via telehealth services, especially for high-risk...more

3/19/2020 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Health Care Providers , Infectious Diseases , Telehealth

Washington Healthcare Update - March 2020 #3

This week in Washington: House passes Families First Coronavirus Response Act, legislation moves to Senate; CMS releases guidance and information on COVID-19....more

3/17/2020 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Medicaid

Washington Healthcare Update - March 2020 #2

This week in Washington: CMS develops additional code for coronavirus lab tests, announces actions to address spread of coronavirus; House passes bill to ban e-cigarette flavors; Grassley says updated Senate Finance drug...more

3/10/2020 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Drug Pricing , E-Cigarettes , Food and Drug Administration (FDA) , GAO , Medicare Advantage , Medicare Part D , Pharmaceutical Industry

Washington Healthcare Update - March 2020 #1

This week in Washington: Hearings scheduled on the U.S. response to the Coronavirus. ...more

3/3/2020 / Biosimilars , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medicaid , Medicare , Medicare Advantage , Pharmaceutical Industry

Washington Healthcare Update - February 2020 #4

Upcoming Hearings/Markups - Wednesday, February 26, 2020 - House Committee on Appropriations, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies: “Department of Health and Human Services...more

2/25/2020 / Biosimilars , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Medicare , Medicare Advantage , Medicare Part D , Prescription Drugs

Washington Healthcare Update - February 2020 #3

This week in Washington: The House and Senate will be in recess the week of Feb. 17 in observation of Presidents Day....more

2/18/2020 / Biosimilars , Centers for Medicare & Medicaid Services (CMS) , Controlled Substances , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , HRSA , Medicaid , Medicare , Medicare Advantage , Medicare Part D , Trump Administration

Washington Healthcare Update - February 2020 #2

This week in Washington: Senate to hold hearing on home healthcare in rural America, House to hold hearing on protecting women's access to reproductive healthcare....more

2/11/2020 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , HRSA , Medicare Part D , Opioid , Prescription Drugs , Trump Administration

Washington Healthcare Update - February 2020 #1

This week in Washington: The House of Representatives passes legislation on fentanyl analogues; Senate continues impeachment trial....more

2/4/2020 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , HRSA , Medicare Advantage , Trump Administration

Washington Healthcare Update - January 2020 #4

This week in Washington: Both the House and Senate are back in session....more

1/28/2020 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Generic Drugs , Health Insurance Portability and Accountability Act (HIPAA) , Medicaid , Pharmaceutical Industry , Prescription Drugs

Washington Healthcare Update - January 2020 #3

This week in Washington: The House is not in session. The Senate will resume the impeachment trial on Tuesday....more

1/22/2020 / Centers for Medicare & Medicaid Services (CMS) , Children's Health Insurance Program (CHIP) , Drug Pricing , Food and Drug Administration (FDA) , HRSA , MACPAC , Medicare , Medicare Advantage , Pharmaceutical Industry , Trump Administration , United States-Mexico-Canada Agreement (USMCA)

Courts and Healthcare Policy in 2020

2019 saw court hearings of a number of cases related to the Affordable Care Act (ACA). Several other Trump administration policies were also challenged, including Medicare payment policies, price transparency, how the...more

1/15/2020 / Affordable Care Act , Association Health Plans , Centers for Medicare & Medicaid Services (CMS) , Contraceptive Coverage Mandate , Cost-Sharing , Drug Pricing , Food and Drug Administration (FDA) , Hospitals , Medicaid , Section 340B , Trump Administration

Washington Healthcare Update - January 2020 #2

Tuesday, January 14, 2020 - House Committee on Energy and Commerce: “A Public Health Emergency: State Efforts to Curb the Opioid Crisis” - The Subcommittee on Oversight and Investigations of the Committee on Energy and...more

1/14/2020 / Centers for Medicare & Medicaid Services (CMS) , Food and Drug Administration (FDA) , GAO , Health Care Providers , HRSA , MACPAC

Washington Healthcare Update - January 2020 #1

Wednesday, Jan. 8, 2020 - House Committee on Energy and Commerce: “Legislation to Improve Americans’ Health Care Coverage and Outcomes” - The Subcommittee on Health of the Committee on Energy and Commerce will hold a...more

1/7/2020 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Outpatient Prospective Payment System (OPPS) , Pharmaceutical Industry , Prescription Drugs

Washington Healthcare Update - December 2019 #3

This Week in Washington: The House and Senate are out of session until the new year. Congress - House - House Passes USMCA Trade Deal ...more

12/24/2019 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , HRSA , Impeachment , Individual Mandate , OIG , Outpatient Prospective Payment System (OPPS) , Trump Administration , United States-Mexico-Canada Agreement (USMCA)

Washington Healthcare Update - December 2019 #2

This Week in Washington: The House and Senate will leave for the holidays by Dec. 20....more

12/17/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Health Care Providers , Hospitals , OIG , Outpatient Prospective Payment System (OPPS) , Pharmaceutical Industry , Prescription Drugs

Washington Healthcare Update - December 2019 #1

This Week in Washington: The House and Senate are back from Thanksgiving recess. Congress is expected to be in session until or about Dec. 20....more

12/10/2019 / Anti-Kickback Statute , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Hospitals , OIG , Outpatient Prospective Payment System (OPPS) , Pharmaceutical Industry , Prescription Drugs , Safe Harbors , Stark Law , Trump Administration

Washington Healthcare Update - November 2019 #4

This week in Washington: The House and Senate are out for Thanksgiving recess this week. Congress - Hearings/Markups - House Committee on the Judiciary: “The Patent Trial and Appeal Board and the Appointments Clause:...more

11/26/2019 / Anti-Kickback Statute , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Draft Guidance , Food and Drug Administration (FDA) , GAO , OIG , Outpatient Prospective Payment System (OPPS) , Prescription Drugs , Transparency

Washington Healthcare Update - November 2019 #3

This week in Washington: Senate to hold a confirmation hearing for Dr. Stephen Hahn, Trump's nominee to be the new FDA commissioner, as well as a hearing on Alzheimer's awareness. ...more

11/19/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , OIG , Outpatient Prospective Payment System (OPPS) , Pharmaceutical Industry , Self-Referral , Stark Law

Washington Healthcare Update - November 2019 #2

This week in Washington: House returns from recess and has scheduled hearing on caring for aging Americans; Senate to hold hearing on rising electronic cigarette use among youth and will hold a confirmation hearing for Dr....more

11/12/2019 / Anti-Kickback Statute , Centers for Medicare & Medicaid Services (CMS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medicare , Medicare Part B , OIG , Pharmaceutical Industry , Prescription Drugs , Safe Harbors , Self-Referral , Stark Law

Stephanie Kennan

McGuireWoods LLP

Readers' Choice Awards

Popular Topics by This Author

Latest Posts › Centers for Medicare & Medicaid Services (CMS)